BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sapphire Therapeutics, Inc. 

1031 US Highway 22
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-231-1435 Fax: 908-231-1459


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Helsinn Healthcare SA Announces the Acquisition of Sapphire Therapeutics, Inc. to Establish Helsinn Therapeutics (US) Inc. 1/28/2009 11:27:12 AM    More...
Sapphire Therapeutics, Inc. Promotes Suzan Allen to Vice President Clinical Operations 2/12/2008 10:12:46 AM    More...
Sapphire Therapeutics, Inc. Licenses Ghrelin Antagonist Program From Novo Nordisk A/S (NVO) for Development of Obesity Treatments 10/30/2007 9:10:24 AM    More...
Sapphire Therapeutics, Inc. Announces Promotions and New Appointment to Management Team 8/9/2007 8:45:15 AM    More...
Sapphire Therapeutics, Inc. to Present Results From Anamorelin Phase 2 Cachexia/Anorexia Studies at American Society of Clinical Oncology and Endocrine Society Annual Meetings in June 4/26/2007 10:27:29 AM    More...
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO 3/27/2007 8:56:37 AM    More...
Sapphire Therapeutics, Inc. Licenses Novel Drug To Ono Pharmaceutical Company, Ltd. In Japan, Korea And Taiwan For The Treatment Of Cancer Anorexia/Cachexia 10/26/2006 10:27:59 AM    More...
Sapphire Therapeutics, Inc. Licenses Ghrelin Mimetic From Novo Nordisk A/S (NVO) 9/19/2006 10:46:55 AM    More...
Sapphire Therapeutics, Inc. Expands Drug Development Team; New CEO, Board Appointment 8/25/2006 10:44:14 AM    More...
Sapphire Therapeutics, Inc. Appoints New Director And Scientific Advisory Board 1/17/2006 11:08:55 AM    More...
12